438 related articles for article (PubMed ID: 10678113)
21. A study protocol for a randomised open-label clinical trial of artesunate-mefloquine versus chloroquine in patients with non-severe Plasmodium knowlesi malaria in Sabah, Malaysia (ACT KNOW trial).
Grigg MJ; William T; Dhanaraj P; Menon J; Barber BE; von Seidlein L; Rajahram G; Price RN; Anstey NM; Yeo TW
BMJ Open; 2014 Aug; 4(8):e006005. PubMed ID: 25138814
[TBL] [Abstract][Full Text] [Related]
22. Suppression of Plasmodium berghei parasitemia by LiCl in an animal infection model.
Nurul Aiezzah Z; Noor E; Hasidah MS
Trop Biomed; 2010 Dec; 27(3):624-31. PubMed ID: 21399604
[TBL] [Abstract][Full Text] [Related]
23. [Ca++ ion transport blockers as reversants of the drug resistance of malarial parasites. 2. The effect of praziquantel on the resistance to chloroquine and compound R-70-Zh of Plasmodium berghei].
Orlov VS; Rabinovich SA; Bukhtin BA; Dadasheva NR; Maksakovskaia EV
Med Parazitol (Mosk); 1998; (1):26-9. PubMed ID: 9608206
[TBL] [Abstract][Full Text] [Related]
24. Antagonism of serum of mice infected with chloroquine-resistant 'NS' line to the antimalarial action of chloroquine.
Li GD; Qian YL; Chen L
Zhongguo Yao Li Xue Bao; 1989 May; 10(3):257-60. PubMed ID: 2692400
[TBL] [Abstract][Full Text] [Related]
25. Patterns of parasitaemia, antibodies, complement and circulating immune complexes in drug-suppressed simian Plasmodium knowlesi malaria.
Biswas S
Indian J Malariol; 1999; 36(1-2):33-41. PubMed ID: 11304917
[TBL] [Abstract][Full Text] [Related]
26. [A fifth plasmodium that can cause malaria].
Myrvang B
Tidsskr Nor Laegeforen; 2010 Feb; 130(3):282-3. PubMed ID: 20160773
[TBL] [Abstract][Full Text] [Related]
27. [Studies on pharmacokinetics of chloroquine in mice infected with chloroquine-resistant strain of Plasmodium berghei].
Shi J; Song GH; Ni YC; Wang MJ
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2000; 18(5):282-5. PubMed ID: 12567636
[TBL] [Abstract][Full Text] [Related]
28. Effect of artemether administered alone or in combination with praziquantel to mice infected with Plasmodium berghei or Schistosoma mansoni or both.
Shu-Hua X; Utzinger J; Chollet J; Tanner M
Int J Parasitol; 2006 Jul; 36(8):957-64. PubMed ID: 16750833
[TBL] [Abstract][Full Text] [Related]
29. Combination effects of chloroquine with the febrifugine and isofebrifugine mixture against a blood-induced infection with chloroquine-resistant Plasmodium berghei NK65 in ICR mice.
Ishih A; Suzuki T; Watanabe M; Miyase T; Terada M
Phytother Res; 2003 Dec; 17(10):1234-6. PubMed ID: 14669265
[TBL] [Abstract][Full Text] [Related]
30. Rifampicin antagonizes the effect of choloroquine on chloroquine-resistant Plasmodium berghei in mice.
Hou LJ; Raju SS; Abdulah MS; Nor NM; Ravichandran M
Jpn J Infect Dis; 2004 Oct; 57(5):198-202. PubMed ID: 15507775
[TBL] [Abstract][Full Text] [Related]
31. Plasmodium berghei: development of an irreversible experimental malaria model in Wistar rats.
Pedroni HC; Bettoni CC; Spalding SM; Dalla Costa T
Exp Parasitol; 2006 Jul; 113(3):193-6. PubMed ID: 16494867
[TBL] [Abstract][Full Text] [Related]
32. Comparison of effects of pyronaridine, amodiaquine, mefloquine and qinghaosu on rodent malaria.
Shao BR; Ye XY; Chu YH
Southeast Asian J Trop Med Public Health; 1992 Mar; 23(1):59-63. PubMed ID: 1523480
[TBL] [Abstract][Full Text] [Related]
33. Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes.
Swarthout TD; van den Broek IV; Kayembe G; Montgomery J; Pota H; Roper C
Trop Med Int Health; 2006 Oct; 11(10):1503-11. PubMed ID: 17002724
[TBL] [Abstract][Full Text] [Related]
34. [Effect of artesunate transdermal preparation on Plasmodium cynomolgi].
Xuan WY; Zhao Y; Li AY; Xie PS; Liu X
Yao Xue Xue Bao; 1990; 25(3):220-2. PubMed ID: 2239338
[TBL] [Abstract][Full Text] [Related]
35. Risk assessment and therapeutic indices of artesunate and artelinate in Plasmodium berghei-infected and uninfected rats.
Xie LH; Johnson TO; Weina PJ; Si Y; Haeberle A; Upadhyay R; Wong E; Li Q
Int J Toxicol; 2005; 24(4):251-64. PubMed ID: 16126619
[TBL] [Abstract][Full Text] [Related]
36. The antimalarial and toxic effect of artesunate on animal models.
Yang QC; Shi WZ; Li R; Gan J
J Tradit Chin Med; 1982 Jun; 2(2):99-103. PubMed ID: 6765851
[No Abstract] [Full Text] [Related]
37. Azithromycin: antimalarial profile against blood- and sporozoite-induced infections in mice and monkeys.
Puri SK; Singh N
Exp Parasitol; 2000 Jan; 94(1):8-14. PubMed ID: 10631075
[TBL] [Abstract][Full Text] [Related]
38. Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar.
Smithuis F; Shahmanesh M; Kyaw MK; Savran O; Lwin S; White NJ
Trop Med Int Health; 2004 Nov; 9(11):1184-90. PubMed ID: 15548314
[TBL] [Abstract][Full Text] [Related]
39. The schizontocidal activity of daphnetin against malaria parasites in vitro and in vivo.
Wang QM; Ni YC; Xu YQ; Ha SH; Cai Y
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2000; 18(4):204-6. PubMed ID: 12567659
[TBL] [Abstract][Full Text] [Related]
40. Increased parasitaemia and delayed parasite clearance in Schistosoma mansoni and Plasmodium berghei co-infected mice.
Legesse M; Erko B; Balcha F
Acta Trop; 2004 Jul; 91(2):161-6. PubMed ID: 15234665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
